Search Results 1381-1390 of 19919 for Receptor

1. Mayo Clinic Minute: 3 things to know when using Narcan during an opioid overdose

   These medications work by blocking pain receptors in the central nervous system. ... "It knocks off the opioid from that receptor, binds to it and prevents the ...

2. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients ...

3. Madiha Iqbal, M.B.B.S., M.D. - Mayo Clinic Faculty Profiles

   SUMMARY. The research of Dr. Madiha Iqbal, M.B.B.S., M.D., pertains to hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR)-T cell ...

4. Understanding the molecular mechanisms that affect motor unit and muscle health during aging - Mayo Clinic

   ... receptors on skeletal muscle. When this happens, there are phosphorylation events intracellularly, and the receptor recruits an enzyme called PI3 kinase ...

5. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Note: Participants receiving proton pump inhibitors who switch to H2-receptor antagonists or antacids are eligible for enrollment to this study. Vaccination ...

6. Innovative CAR-TIL immunotherapy against melanoma - Mayo Clinic

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

7. A Study to Investigate Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache - Mayo Clinic

   Has previously received any CGRP ligand or receptor targeted monoclonal antibody. Eligibility last updated 1/19/22. Questions regarding updates should be ...

8. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...

9. Research of Experimental COVID-19 Therapeutics Explained - Mayo Clinic News Network

   The monoclonal antibody drugs block the receptor for interleukin 6, thereby preventing it from reaching cells. However, both drugs failed to show benefit ...

10. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

    Patients must not have a known epidermal growth factor receptor (EGFR) mutation or anaplastic lymphoma kinase (ALK) fusion; Patients must have Zubrod ...